Ombudsman Clears EMA in Rejection of Over-the-Counter Migraine Drug

International Pharmaceutical Regulatory Monitor
A A
The European Medicines Agency acted properly in rejecting a UK-based pharmaceutical company’s over-the-counter migraine medicine, the European ombudsman says.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor

Buy This Article Now

Add this article to your cart for $40.00